Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 56 of 157 for:    Idiopathic Dilated Cardiomyopathy

Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart Failure (CHF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00934609
Recruitment Status : Completed
First Posted : July 8, 2009
Last Update Posted : September 18, 2009
Sponsor:
Collaborator:
The German Heart Foundation
Information provided by:
Saarland University

Brief Summary:
The study investigates the safety and effectiveness of a 12 week endurance training program for patients with chronic heart failure

Condition or disease Intervention/treatment Phase
Dilated Cardiomyopathy Chronic Heart Failure Behavioral: Endurance training Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 66 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effects of 12-weeks Endurance Training in Patients With Chronic Heart Failure Due to Dilated Cardiomyopathy


Arm Intervention/treatment
Experimental: Training
12 weeks of endurance training on the cycle ergometer under supervision on a physician
Behavioral: Endurance training
45 min ergometer cycling at the ventilatory anaerobic threshold 4 times per week for 12 weeks

No Intervention: Control
Control condition



Primary Outcome Measures :
  1. Physical capacity

Secondary Outcome Measures :
  1. Left ventricular function
  2. occurence of complications [ Time Frame: within study period ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • chronic heart failure NYHA stage 2 and 3

Exclusion Criteria:

  • Valvular disease
  • recent decompensation
  • Other complaints that might interfere with ergometer exercise

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00934609


Locations
Layout table for location information
Germany
Institute of Sports- and Preventive Medicine, Saarland University
Saarbrücken, Saarland, Germany, 66123
Sponsors and Collaborators
Saarland University
The German Heart Foundation

Layout table for additonal information
Responsible Party: Prof. Dr. Tim Meyer, Institute of Sports- and Preventive Medicine, Saarland University
ClinicalTrials.gov Identifier: NCT00934609     History of Changes
Other Study ID Numbers: 2000-01SaarlandU
First Posted: July 8, 2009    Key Record Dates
Last Update Posted: September 18, 2009
Last Verified: September 2009
Keywords provided by Saarland University:
Exercise
heart failure
dilated cardiomyopathy
Endurance training
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Cardiomyopathies
Cardiomyopathy, Dilated
Heart Diseases
Cardiovascular Diseases
Cardiomegaly